Detection of high-level tetracycline resistance in clinical isolates of Helicobacter pylori using PCR-RFLP

被引:38
作者
Ribeiro, ML
Gerrits, MM
Benvengo, YHB
Berning, M
Godoy, APO
Kuipers, EJ
Mendonça, S
van Vliet, AHM
Pedrazzoli, J
Kusters, JG
机构
[1] Erasmus Univ, Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, NL-3015 GD Rotterdam, Netherlands
[2] Univ Sao Francisco, Sch Med, Clin Pharmacol & Gastroenterol Unit, BR-12900000 Braganca Paulista, SP, Brazil
来源
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY | 2004年 / 40卷 / 01期
基金
巴西圣保罗研究基金会;
关键词
antibiotic resistance; tetracycline; gastric disease; peptic ulcer; polymerase chain reaction-restriction fragment length polymorphism; Helicobacter pylori;
D O I
10.1016/S0928-8244(03)00277-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tetracycline is one of four antibiotics commonly used for the treatment of Helicobaeter pylori infection, but its effectiveness is decreasing as the incidence of tetracycline resistance is increasing. In five Brazilian tetracycline-resistant (Tet(R)) H. pylori isolates, high-level tetracycline resistance is mediated by the triple-base-pair substitution AGA(926-928) --> TTC in both 16S rRNA genes, as was previously observed in two independent high-level Tet(R) H. pylori strains. A polymerase chain reaction-based restriction fragment length polymorphism (PCR-RFLP) assay was developed for the detection of the AGA(926-928) --> TTC substitution, and confirmed the presence of the aforementioned triple-base-pair substitution in all five Brazilian TetR isolates. This PCR-RFLP-based approach distinguishes the high-level Tet(R) isolates from low-level Tet(R) and Tet(S) H. pylori strains and thus allows the direct detection of Tet(R) H. pylori isolates. (C) 2003 Federation of European Microbiological Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:57 / 61
页数:5
相关论文
共 22 条
[1]   Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori [J].
Alm, RA ;
Ling, LSL ;
Moir, DT ;
King, BL ;
Brown, ED ;
Doig, PC ;
Smith, DR ;
Noonan, B ;
Guild, BC ;
deJonge, BL ;
Carmel, G ;
Tummino, PJ ;
Caruso, A ;
Uria-Nickelsen, M ;
Mills, DM ;
Ives, C ;
Gibson, R ;
Merberg, D ;
Mills, SD ;
Jiang, Q ;
Taylor, DE ;
Vovis, GF ;
Trost, TJ .
NATURE, 1999, 397 (6715) :176-180
[2]   The structural basis for the action of the antibiotics tetracycline, pactamycin, and hygromycin B on the 30S ribosomal subunit [J].
Brodersen, DE ;
Clemons, WM ;
Carter, AP ;
Morgan-Warren, RJ ;
Wimberly, BT ;
Ramakrishnan, V .
CELL, 2000, 103 (07) :1143-1154
[3]   Tetracycline antibiotics: Mode of action, applications, molecular biology, and epidemiology of bacterial resistance [J].
Chopra, I ;
Roberts, M .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 2001, 65 (02) :232-+
[4]   Emergence of tetracycline resistance in Helicobacter pylori:: Multiple mutational changes in 16S ribosomal DNA and other genetic loci [J].
Dailidiene, D ;
Bertoli, MT ;
Miciuleviciene, J ;
Mukhopadhyay, AK ;
Dailide, G ;
Pascasio, MA ;
Kupcinskas, L ;
Berg, DE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (12) :3940-3946
[5]   Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands [J].
Debets-Ossenkopp, YJ ;
Herscheid, AJ ;
Pot, RGJ ;
Kuipers, EJ ;
Kusters, JG ;
Vandenbroucke-Grauls, CMJE .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 43 (04) :511-515
[6]   Helicobacter pylori [J].
Dunn, BE ;
Cohen, H ;
Blaser, MJ .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (04) :720-+
[7]   Effects of 16S rRNA gene mutations on tetracycline resistance in Helicobacter pylori [J].
Gerrits, MM ;
Berning, M ;
Van Vliet, AHM ;
Kuipers, EJ ;
Kusters, JG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (09) :2984-2986
[8]   16S rRNA mutation-mediated tetracycline resistance in Helicobacter pylori [J].
Gerrits, MM ;
de Zoete, MR ;
Arents, NLA ;
Kuipers, EJ ;
Kusters, JG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (09) :2996-3000
[9]   Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail [J].
Gisbert, JP ;
Pajares, JM .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (06) :1047-1057
[10]   Helicobacter pylori therapy:: First-line options and rescue regimen [J].
Gisbert, JP ;
Pajares, JM .
DIGESTIVE DISEASES, 2001, 19 (02) :134-143